Author´s correction note

Upon reviewing our recently published research article [1], we noticed that some of the data presented in the manuscript and on the tables were incorrectly presented. These mistakes do not change the overall conclusions regarding the high accuracy of miR-203 and miR-205 as diagnostic markers of neck metastases in HNSCC.

Corrected text

1. (Page 8: End of “Validation and diagnostic accuracy of miR-203 and miR-205 expression in FNA samples”)

Please replace

All in all, the sensitivity rate for both markers was 92.9 % (39/42, CI 95 %, 80.5–98.4), with a specificity level of 100 % (71/71, CI 95 %, 94.9–100) (Table 2; Figure 6B).

Table 2 Sensitivity and specificity values of microRNAs evaluated in discriminating metastatic and non-metastatic lymph nodes in FFPE and FNA biopsies from lymph node samples

With the amended text

All in all, the sensitivity rate for both markers was 93.3 % (42/45, CI 95 %, 81.7–98.6), with a specificity level of 100 % (68/68, CI 95 %, 94.7–100) (Table 2; Figure 6B).

Table 2 Sensitivity and specificity values of microRNAs evaluated in discriminating metastatic and non-metastatic lymph nodes in FFPE and FNA biopsies from lymph node samples

2. (Page 8: End of “Validation and diagnostic accuracy of miR-203 and miR-205 expression in FNA samples”)

Please replace

Moreover, negative predictive values were of 95.9 % (95 % CI, 88.6–99.1 %) and positive predictive values of 100 % (95 % CI, 90.9–100 %) for both microRNAs (Table 3).

Table 3 Accuracy characteristics of microRNAs in discriminating metastatic and non-metastatic lymph nodes in FFPE and FNA biopsies from lymph node samples

With the amended text

Moreover, negative predictive values were of 95.9 % (95 % CI, 88.6–99.1 %) and positive predictive values of 100% (95 % CI, 91.5–100 %) for both microRNAs (Table 3).

Table 3 Accuracy characteristics of microRNAs in discriminating metastatic and non-metastatic lymph nodes in FFPE and FNA biopsies from lymph node samples